Loading…
To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of all contact lenses as medical devices, and for other purposes.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
93pct
201d open
vs 5,354 other HR bills in the 108th — cohort avg 50d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
H.R.2218 Regulation of non corrective contact lens as medical devices S.1 Prescription Drug and Medicare Improvement Act of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1288/S.1037 Access to Cancer Therapies Act of 2003 S.178 Comprehensive Immunosuppressive Drug Coverage for Transplant patients Act of 2003 S.191/H.R.2223 Immunosuppressive drug Coverage Act of 2003 H.R.2356 Prescription Drug Comparative Effectiveness Act of 2003 S.650/H.R.2857 Pediatric Research Equity Act of 2003 H.R.2769 Save our Seniors Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1170 Child Medication Safety Act of 2003 H.R.2218 Federal Food, Drug, and Cosmetic Act Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy - Senator jeffords, Bennett, Leahy, Kennedy bills Prospective Payment system Gene Therapy Drug Reimportation Medicare Reform Agriculture Appropriation 2001 - Drug Reimportation Agriculture Appropriation 2001 (FDA Funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,640,102 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218 Regulation of non corrective contct lens as medical devices S1 Prescription Drug and Medicare Improvement oAct of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical market Access Act of 2003 H.R.2857 Pediatric Research Equity Act of 2003 H.R.1170 Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modernization Act the Bipartisan Medicare Prescription Drug Act of 2001 (Sen.Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,640,102 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218 Regulation of non corrective contct lens as medical devices S1 Prescription Drug and Medicare Improvement oAct of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical market Access Act of 2003 H.R.2857 Pediatric Research Equity Act of 2003 H.R.1170 Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modernization Act the Bipartisan Medicare Prescription Drug Act of 2001 (Sen.Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,958,138 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218 Regulation of non corrective contact lens as medical devices S.1 Prescription Drug and Medicare Improvement Act of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1288/S.1037 Access to Cancer Therapies Act of 2003 S.178 Comprehensive Immunosuppressive Drug Coverage for Transplant patients Act of 2003 S.191/H.R.2223 Immunosuppressive drug Coverage Act of 2003 H.R.2356 Prescription Drug Comparative Effectiveness Act of 2003 S.650/H.R.2857 Pediatric Research Equity Act of 2003 H.R.2769 Save our Seniors Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1170 Child Medication Safety Act of 2003 H.R.2218 Federal Food, Drug, and Cosmetic Act S.874/H.R.1736 Sickle Cell Treatment Act Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy - Senator jeffords, Bennett, Leahy, Kennedy bills Prospective Payment system Gene Therapy Drug Reimportation Medicare Reform Agriculture Appropriation 2001 - Drug Reimportation Agriculture Appropriation 2001 (FDA Funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,958,138 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
2003 · year_end · Health Issues
Pl-107-250-Medical Device User Fee and Modernization Act of 2002. (Bill that became the law to finance faster FDA reviews of new medical devices and to make improvements in the regulation of medical devices.) H.R.3493/S.1881-Medical Devices Technical Corrections Act. (Bills to make technical corrections relating to the amendments made by the Medical Device User Fee and Modernizatoin Act of 2002.) S.15/H.R.2122-Project BioShield Act of 2003. S.754-Improved Vaccine Affordability and Availability Act. (Bills to enhance, research, development, procurement, and use of biomedical countermeasures to respond to public health threats affecting national security.) S.877-Patient Safety Improvement Act of 2003. H.R. 663/S.720-Patient Safety and Quality Improvement Act. S. 1775/H.R. 3038-Healthcare Safety Net Amendments Technical Corrections Act of 2003. (Bills intended to provide for the improvement of patient safety and to reduce the incidence of medical errors that adversely affect patient safety.) H.R.5-Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003. S.11-Patients First Act of 2003. (Bills to improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.) H.R.3140 (PL 108-164)/H.R.2221-Fairness to Contact Lens Consumers Act. H.R.2218/S.1747-To Amend Food and Drug, and Cosmetic Act to Provide for the regulation of all contact lenses as medical devices, and for other purposes. (Bills to regulate all contact lenses as medical devices.) S. Con. Res.80/H. Con. Res. 324-Concurrent resolution urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreeement on Medical Equipment and Pharmaceuticals, and for other purposes. (Bills providing that the revolution in medical technology has improved our ability to respond to emerging threats and prevent, identify, treat, and cure a broad range of diseases and disabilities, and has the proven potential to bring even more valuable advances in the future.) H.R.1828-Syria Accountability and Lebanese Sovereignty Restoration Act of 2003. (Section of the bill related to lifting sanctions against export of medical devices as related to Syria and Lebanon.) H.R.1561-United States Patent and Trademark Fee Modernizaton Act of 2003. (The bill to lower patent filing and basic national fees as related to medical devices.)
H.R.2218 Regulation of non corrective contact lens as medical devices S.1 Prescription Drug and Medicare Improvement Act of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R 1288/S.1037 Access to Cancer Therapies Act of 2003 S.178 Comprehensive Immunospuppressive Drug Coverage for Transplant patients Act of 2003 S.191/H.R.2223 Immunosuppressive drug Coverage Act of 2003 H.R.588 Medicare Fairness for Organ Transplant Recipients Act of 2003 H.R.2356 Prescription Drug Comparative Effectiveness Act of 2003 S.650/H.R.2857 Pediatric Research Equity Act of 2003 H.R.2769 Save our Seniors Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R. 1170 Child Medication Safety Act of 2003 H.R.2218 Federal Food, Drug, and Cosmetic Act Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy - Senator Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture Appropriation 2001 - Drug Reimportation Agriculture Appropriation 2001 (FDA Funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen.Kennedy-Draft Bill)
Client expense: $1,474,129 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
HR2218 Regulation of non corrective contact lens as medical devices S1 Prescription Drug and Medicare Improvement Act of 2003 HR1 Medicare Prescription Drug Modernization Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857 Pedicatric Research Equity Act of 2003 HR1170 Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modernization Act The Bipartisan Medicare prescription Drug Act of 2001 (Sen.Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,474,129 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
| Democratic |
| NY |
| Ernest Fletcher | Republican | KY |
| Ernest Istook | Republican | OK |
| Fortney Pete Stark | Democratic | CA |
| Gene Green | Democratic | TX |
| Grace F. Napolitano | Democratic | CA |
| Henry A. Waxman | Democratic | CA |
| Janice D. Schakowsky | Democratic | IL |
| Jerry Moran | Republican | KS |
| Michael Bilirakis | Republican | FL |
| Michael C. Burgess | Republican | TX |
| Mike Rogers | Republican | MI |
| Raúl M. Grijalva | Democratic | AZ |
| Richard Burr | Republican | NC |
| Rosa L. DeLauro | Democratic | CT |
| Sherrod Brown | Democratic | OH |
| Victor Snyder | Democratic | AR |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $2,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE